These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
70 related items for PubMed ID: 8243566
21. Effects of GM-CSF, IL-3, and GM-CSF/IL-3 fusion protein on apoptosis of human myeloid leukemic cell line Tf-1 induced by irradiation. Yang SR, Wen L, Lu YQ, Gong QY, Yu R, Yao MH. Acta Pharmacol Sin; 2004 Jan; 25(1):68-75. PubMed ID: 14704125 [Abstract] [Full Text] [Related]
22. Differential regulation by hematopoietic growth factors of apoptosis and mitosis in acute myeloblastic leukemia cells. Murohashi I, Yoshida K, Handa A, Murayoshi M, Yoshida S, Jinnai I, Bessho M, Hirashima K. Exp Hematol; 1997 Sep; 25(10):1042-50. PubMed ID: 9293901 [Abstract] [Full Text] [Related]
23. Interleukin 6 induces DNA binding activity of AP1 in M1 myeloblastic cells but not in a growth resistant cell derivative. Melamed D, Resnitzky D, Haimov I, Levy N, Pfarr CM, Yaniv M, Kimchi A. Cell Growth Differ; 1993 Aug; 4(8):689-97. PubMed ID: 8398910 [Abstract] [Full Text] [Related]
24. Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells. Ozpolat B, Akar U, Steiner M, Zorrilla-Calancha I, Tirado-Gomez M, Colburn N, Danilenko M, Kornblau S, Berestein GL. Mol Cancer Res; 2007 Jan; 5(1):95-108. PubMed ID: 17259349 [Abstract] [Full Text] [Related]
25. p53-independent apoptosis associated with c-Myc-mediated block in myeloid cell differentiation. Amanullah A, Liebermann DA, Hoffman B. Oncogene; 2000 Jun 15; 19(26):2967-77. PubMed ID: 10871848 [Abstract] [Full Text] [Related]
26. Bone marrow fibroblast exposure to the inflammatory cytokines tumor necrosis factor-alpha and interferon-gamma increases adhesion of acute myeloid leukemia cells and alters the adhesive mechanism. Bendall LJ, Kortlepel K, Gottlieb DJ. Exp Hematol; 1997 Feb 15; 25(2):132-9. PubMed ID: 9015213 [Abstract] [Full Text] [Related]
27. Effects of all-trans retinoic acid and antireceptor antibodies on growth and programmed cell death of human myeloma cells. Taetle R, Dos Santos B, Akamatsu K, Koishihara Y, Ohsugi Y. Clin Cancer Res; 1996 Feb 15; 2(2):253-9. PubMed ID: 9816167 [Abstract] [Full Text] [Related]
28. Stem cell factor and PIXY-321 in acute lymphoblastic leukemia: in vitro study on proliferative effects and apoptosis. Petrucci MT, De Felice L, Ricciardi MR, Ariola C, Mascolo MG, Fenu S, Tafuri A. Cytokines Mol Ther; 1996 Dec 15; 2(4):225-30. PubMed ID: 9384708 [Abstract] [Full Text] [Related]
29. Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1. Eischen CM, Packham G, Nip J, Fee BE, Hiebert SW, Zambetti GP, Cleveland JL. Oncogene; 2001 Oct 25; 20(48):6983-93. PubMed ID: 11704823 [Abstract] [Full Text] [Related]
30. Apoptosis-related gene expression affected by a GnRH analogue without induction of programmed cell death in LNCaP cells. Angelucci C, Iacopino F, Lama G, Capucci S, Zelano G, Boca M, Pistilli A, Sica G. Anticancer Res; 2004 Oct 25; 24(5A):2729-38. PubMed ID: 15517879 [Abstract] [Full Text] [Related]
31. [The protective effect of interleukin-1 receptor antagonist on postischemic reperfused myocardium and its possible mechanism]. Li YJ, Ding WH, Gao W, Huo Y, Hong T, Zhu RY, Ma DL. Zhonghua Yi Xue Za Zhi; 2004 Apr 02; 84(7):548-53. PubMed ID: 15144587 [Abstract] [Full Text] [Related]
32. High-dose mitoxantrone induces programmed cell death or apoptosis in human myeloid leukemia cells. Bhalla K, Ibrado AM, Tourkina E, Tang C, Grant S, Bullock G, Huang Y, Ponnathpur V, Mahoney ME. Blood; 1993 Nov 15; 82(10):3133-40. PubMed ID: 8219202 [Abstract] [Full Text] [Related]
33. VP-16-mediated cytotoxicity is modulated by interleukin-3 in a growth factor-dependent leukemic cell line. Vellenga E, Asschert L, Withoff S, van der Kolk D, de Vries EG. Leukemia; 1994 Dec 15; 8(12):2060-4. PubMed ID: 7807995 [Abstract] [Full Text] [Related]
35. Differential effect of 4-hydroperoxycyclophosphamide and antimyeloid monoclonal antibodies on T and natural killer cells during bone marrow purging. Zhong RK, Donnenberg AD, Rubin J, Ball ED. Blood; 1994 Apr 15; 83(8):2345-51. PubMed ID: 7512845 [Abstract] [Full Text] [Related]
36. Enhanced cytotoxic interaction between 5-fluorouracil and 4-hydroperoxycyclophosphamide against L1210 murine leukemic cells: applicability to ex vivo purging. Mao XY, Higashigawa M, M'Soka T, Shimono Y, Nagata T, Inamochi H, Cao DC, Hori H, Kawasaki H, Sakurai M. Cancer Invest; 1999 Apr 15; 17(7):486-93. PubMed ID: 10518193 [Abstract] [Full Text] [Related]
37. Repair analysis of 4-hydroperoxycyclophosphamide-induced DNA interstrand crosslinking in the c-myc gene in 4-hydroperoxycyclophosphamide-sensitive and -resistant medulloblastoma cell lines. Dong Q, Bullock N, Ali-Osman F, Colvin OM, Bigner DD, Friedman HS. Cancer Chemother Pharmacol; 1996 Apr 15; 37(3):242-46. PubMed ID: 8529284 [Abstract] [Full Text] [Related]
38. In vitro synergism of 4-hydroperoxycyclophosphamide and cisplatin: relevance for bone marrow purging. Peters RH, Brandon CS, Avila LA, Colvin OM, Stuart RK. Cancer Chemother Pharmacol; 1989 Apr 15; 23(3):129-34. PubMed ID: 2924369 [Abstract] [Full Text] [Related]
39. Rescue from programmed cell death in leukemic and normal myeloid cells. Lotem J, Cragoe EJ, Sachs L. Blood; 1991 Aug 15; 78(4):953-60. PubMed ID: 1651136 [Abstract] [Full Text] [Related]
40. Purging effect of dibutyl phthalate on leukemic cells associated with apoptosis. Lisheng W, Chutse W, Xuetao P, Li X, Jurong C, Fuchu H. Leuk Res; 1996 Aug 15; 20(11-12):989-92. PubMed ID: 9009259 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]